News

Funds were awarded under the National Institute of Allergy and Infectious Diseases (NIAID) Biodefense Challenge Grants program, which encourages private industry to work with academic investigators in order

Insulin-dependent diabetes is caused by the destruction of the insulin-producing cells in the pancreas, called islet cells, by auto-reactive T cells. The loss of insulin results in an

Under the agreement, Adolor is responsible for conducting clinical trials, managing the approval process and, upon receipt of marketing approval, commercializing the product in North America. “If LidoPAIN

Immunologists have previously used synthetic peptides to stimulate immunity to viruses and cancers where naturally-occurring peptides were failing. However, many of these peptides have been unstable and degraded

The four US patents provide additional protection for systemic delivery of drugs in specific therapeutic areas, namely analgesics, hormones, anti-Parkinson’s agents and anti-emetics. These are “continuation in part”

The submission seeks approval for two strengths of the drug and is based on 27 phase I, II and III trials designed to assess the efficacy and safety

Sevoflurane is an inhaled anesthetic originally developed by Baxter in the 1970s. The company licensed the patents for making the product in the 1980s to Maruishi Pharmaceutical, which

The results from work done at the Centre of Translational Research in Cancer of the Jewish General Hospital in Montreal showed a potent delay of tumor growth following

Avastin, which is already approved by the FDA as a first-line treatment for metastatic colorectal cancer, is designed to interfere with the blood supply to tumors, a process